A Linear Ablating System in the Left and Right Atrium: Feasibility, Catheter Performance and Clinical Results  by Arujuna, Aruna et al.
www.ipej.org 82
Original Article 
A Linear Ablating System in the Left and Right Atrium: 
Feasibility, Catheter Performance and Clinical Results
Aruna Arujuna MBChB, MRCP; Cliona Murphy MBBS, MRCP, MD; Azmat Hayat MD; 
Hollie Seffens; Jaswinder S Gill MA, MD, FRCP.
Cardiothoracic Centre, Guy's and St Thomas' Hospitals, London, UK
Address for Correspondence: Dr JS Gill, Cardiothoracic Centre, Guy's and St Thomas' 
Hospitals,
Lambeth Palace Road, London SE1 7EH, UK. E-mail: Jaswinder.gill/at/gstt.nhs.uk
Financial Support: Cardima. 
Abstract
Introduction: We describe the use of a ablating system to compartmentalise and regionally 
isolate the atria in paroxysmal and persistent atrial fibrillation (AF).                          
Methods: 40  patients  were  studied,  25  paroxysmal  AF and 14 persistent  AF.  One patient 
enrolled was later found to be in left atrial flutter and was excluded. The Cardima Revelation® 
TX  catheter  system  with  Intellitemp®  Radiofrequency  (RF)  energy  control  device  and  a 
Medtronic Atakar® RF generator were used to place wide area circumferential ablations to 
achieve conduction block into the left and right sided pulmonary veins. Roof lines and mitral 
isthmus lines were also performed. In patients with persistent AF and in repeat procedures, 
right atrial compartmentalisation was performed with an anterior superior vena cava (SVC) to 
inferior vena cava (IVC) line and a septal SVC to IVC line.                                   
Results: At 6 months, 18 of the 39 patients were asymptomatic, 10 had improved symptoms 
and 22 were in sinus rhythm. In the paroxysmal group, 11 were asymptomatic, 7 had improved 
symptoms and 16 (64%) were in sinus rhythm.  In the persistent group, 7 were asymptomatic, 
3 had improved symptoms and 6 (43%) were in sinus rhythm. The total group AF burden was 
37.8 ± 5.4 hrs pre-procedure and 23.1 ±5.1 hrs at 6 months post procedure. Mean temperature, 
impedance and power recorded at each pole demonstrated effective power delivery at all poles. 
No  catheter  charring  was  observed,  complication  rates  were  comparable  to  standard  AF 
ablation  technique.                                     
Conclusion: Linear ablation in the left and right atria to mimic Cox's Maze is feasible and safe 
using  this  ablating  system.                                                
Keywords: Atrial fibrillation, linear ablation, catheter performance, clinical outcome             
            
Introduction
Paroxysmal atrial fibrillation (AF) is frequently initiated by triggers in the pulmonary veins.  
Pulmonary vein isolation (PVI) can eliminate the AF triggers from entering the left atrium and 
prevent occurrence of AF [1]. Linear ablation theoretically creates "lines of block" which 
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disperse  the  refractory  periods  hence  reducing  the  capability  of  atrium to  sustain  AF [2]. 
Surgically deployed intra-operative linear atrial lines, as in Cox's Maze operation[3] are highly 
effective in reducing the occurrence of AF even in patients in very diseased atria [4,5]. This 
has  led  to  the  presumption  that  the  same  success  can  be  achieved  with  catheter  based 
techniques, however these attempts have met with variable success [6]. Procedure times are 
long and it can be difficult to ascertain whether an ablation line is complete. Even if a line 
appears  complete  at  the time of  the procedure,  gaps can appear  in  the subsequent  healing 
process leading to recurrent arrhythmia. Incomplete linear lesions can be pro-arrhythmic and 
predispose  to  new  arrhythmias,  in  particular  left  atrial  flutter  [7].  Investigators  reported 
improved  ablation  success  rates  by  the  addition  of  linear  lines  to  the  PVI  procedure,  in 
particular the mitral isthmus line [8] and the left atrial roof line [9]. A recent evaluation of the 
efficacy  of  LA  linear  ablation  using  a  hexapolar  linear  multi-electrode  mapping/ablation 
catheter has described safety and acute outcomes [10]. In this  study, we propose to assess 
safety and 6 month clinical outcome following PVI and linear ablation using a multi-electrode 
ablation catheter to create continuous linear lines in the left and right atria. This study is a 
preliminary  report  of  the  use  of  the  Cardima Revelation  T-flex  ablating  system® for  this 
purpose.  The approach is similar  to the Cox Surgical  Maze,  but is  less invasive,  therefore 
carrying a lower risk of complication and a shorter recovery time.                        
Catheter  ablation  system  –  description                                    
i)  Linear  ablation  catheter  (Revelation  T-flex  ®)                                      
The Revelation  T-flex® linear  ablation  catheter  is  a  single  use  deflectable  multi-electrode 
electrophysiology  catheter  designed  to  record  intracardiac  potentials  and  deliver 
radiofrequency energy for cardiac tissue ablation. The catheter has a linear configuration and is 
deflectable in one plane (Figure 1a), measuring 150cm in length with electrode spacing of 
2mm. The shaft has 16 signal recording electrodes and 16 ablation coils, each 3mm in length, 
with dual thermocouples at each electrode. The flexible coiled electrodes are integrated into 
the catheter and create deep continuous curvilinear transmural lesions. The thin lesions result 
in  less  surrounding  myocardial  tissue  damage.  Thermocouples  are  integrated  between 
electrodes to sense tissue temperature and sensing occurs through the coils. The catheter has a 
single  plane  of  deflection  and  RF  energy  can  be  delivered  through  up  to  8  electrodes 
simultaneously. The catheter has an atraumatic platinum tip coil for added safety. The catheter 
dimensions are: outer diameter 5.5 French, working length 130cm, curve reach 4cm, electrode 
length 3mm. In comparison to standard "drag and burn" ablation technologies, simultaneous 
ablation through multiple electrodes of a linear ablation catheter may shorten procedure time, 
in theory creating lesions that have penetrating depth without gaps along the linear trajectory. 
Figure  1a: Image of the Cardima Revelation T-flex Linear Ablation Catheter depicting its curve reach sheath
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ii)  Deflectable  guiding  catheter/sheath  (Naviport  ®)                                 
The Naviport torqueable support sheath can be used with the Revelation ablation catheter to 
provide additional support deflectability and maneuverability. It has a radiopaque shaft with a 
soft atraumatic tip. (Figure 1b).
Figure 1b: Image of the Cardima Naviport steerable sheath
 
iii)  Energy  Management  Device  (Intellitemp®)                                      
The  Intellitemp®  Energy  Management  Device  (EMD)  is  used  in  conjunction  with  the 
Revelation  ablation  catheter  to  control  the  delivery of  radio-frequency (RF) energy during 
ablation. RF energy can be applied at  individual  electrodes or in a combination of up to 8 
electrodes simultaneously (the proximal or distal set of the 16 electrodes or any combination of 
eight electrodes). Thermocouples provide direct temperature feedback from the tissue to the 
EMD which modulates  the  RF energy to  each individual  electrode  based on the  recorded 
temperature in order to create optimal  lesion formation.  The feedback system incorporates 
impedance in addition to temperature and impedance out of set limits will result in that pole 
being  switched  off  during  energy  application.                                         
This study was performed to assess several outcomes. Firstly to study the feasibility of creating 
linear ablation lines in the left and right atria using the Revelation T-flex catheter ablating 
system and to perform an evaluation of the catheter performance, assessing RF energy delivery 
and temperatures achieved. The second aim was to assess the practical use of the system in 
routine clinical workflow by evaluation of procedural and screening times.                        
Next, outcome evaluation of both acute ablation success with this system and clinical follow-
up data at 3 and 6 months post catheter ablation of symptoms, rate of recurrence of AF and AF 
burden.  The  final  objective  was  to  document  the  safety  of  this  ablating  catheter  system.
Methods
Study  patients                                   
This prospective study was commenced following formal approval by the local hospital ethics 
committee.  40 consecutive patients with paroxysmal or persistent AF were enrolled for the 
study after informed written consent had been obtained. All patients enrolled into the study had 
documented symptomatic paroxysmal or persistent atrial fibrillation (AF) whilst taking one or 
more anti-arrhythmic medications.  AF was defined as persistent if present for > 7 days or a 
DC  cardioversion  attempt  had  failed.                                   
These  patients  in  AF  had  associated  recognizable  symptoms  such  as  shortness  of  breath, 
palpitations, lightheadedness or fatigue.  'Refractory' AF was defined as a failed rhythm control 
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after trial of two or more anti-arrhythmic drugs (AAD) or Amiodarone alone. AAD failure was 
defined as the occurrence of AF after taking AADs for at least one month. In all patients the 
AAD regimen had to be stable without changes in the regimen/dosage in the previous month.  
The following exclusion criteria were applied - asymptomatic AF patients, patients unable to 
take formal anticoagulation therapy pre/post procedure or the presence of a left atrial clot seen 
on  pre-procedure  trans-oesophageal  echocardiogram.                                
Patient  symptoms  and AF burden                                                  
In  each  patient  symptoms  were  documented  and AF burden measured  by 72 hour  Holter 
monitoring (Getemed GE) at three clinic visits; before the procedure, three months and six 
months post procedure. Holter recordings were analysed using a Cardioday software system 
(GE  version  11.0  for  windows)  with  visual  verification.                             
Ablation  procedure  protocol                                                  
Two trans-septal punctures were performed to access the left atrium and angiograms of the left 
and right sided pulmonary veins were taken with contrast injection. Through the trans-septal 
sheaths an Optima Inquiry® catheter (St Jude Medical) and the T-flex ablation catheter, were 
deployed in the left atrium (Figure 2 a-d). Left atrial geometry was created using the NavX 
system (Ensite/St Jude) with a 6 French screw in reference catheter positioned in the right 
atrium as a geometry reference. The activated clotting time was maintained between 250 and 
300 sec with intravenous heparin throughout the procedure.
Figure 2 a): Ablation catheter position during WACA of the left pulmonary veins (LAO projection)
Figure 2 b):  Ablation catheter position during WACA of the right pulmonary veins (AP projection)
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Figure 2 c):   Ablation catheter placement during Left Atrial Roofline
Figure 2 d): Ablation catheter position during right atrial linear ablation
The Revelation T-flex ablation catheter with the Intellitemp energy management device and 
Medtronic Atakar radiofrequency generator were used to deliver radiofrequency ablation. The 
settings for energy delivery were temperature set at 50°C for 60-90 seconds with an impedance 
range of 190 to 247 ohms. Wide area circumferential  ablations were performed to achieve 
conduction block into the left and right sided pulmonary veins, confirmed by the absence of 
significant  signals  within  each vein  post  ablation.  The Optima  Inquiry® catheter  (St  Jude 
Medical)  was  used  pre  and post  ablation  to  confirm successful  pulmonary  vein  isolation. 
Coronary  sinus  pacing  was  also  undertaken  where  necessary  for  confirmation  of  block.  
Independent pulmonary vein potentials in the absence of atrial capture confirmed pulmonary 
vein isolation. Linear ablation lines were next drawn along the roof between the left and right 
superior  veins  and  from  the  left  lower  pulmonary  vein  to  the  mitral  valve  annulus. 
Confirmation  of  block  across  the  two  ablation  lines  was  not  performed.  Additionally,  in 
patients with persistent atrial fibrillation or redo procedures, right atrial compartmentalisation 
with an anterior  SVC-IVC line and septal  SVC-IVC line was performed.  Confirmation  of 
block across the right atrial  lines was not attempted.  However, in this department we have 
previously  performed  right  atrial  linear  ablation  for  compartmentalisation,  confirming 
conduction  block  after  ablation  by  pacing  on  either  side  of  the  line  and  following  the 
conduction  wavefront  with  an  Ensite  array® (St  Jude)  deployed  in  the  right  atrium.  The 
ablation  catheter  performance  was  assessed  in  the  first  29  patients  studied.  Catheter 
temperature (°C), power (Watts) and impedance (Ohms) were recorded at each pole for each 
application, with mean values then calculated per pole and per patient.                         
Follow-up
Two  follow-up  visits  were  performed,  at  three  and  six  months  post  procedure.  Patients 
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remained on their previous anti-arrhythmic medication for at least 3 months after the ablation 
procedure and those in stable  sinus rhythm after 6 months  had anti-arrhythmic medication 
discontinued or reduced as appropriate. Anticoagulation post procedure was continued with 
warfarin.  
Data  Analysis                                          
Categorical  variables  are  expressed  as  frequencies  and  percentages.  Continuous  data  are 
presented  as  mean value  ± standard deviation  (SD) or  median.  Continuous variables  were 
analysed with the student's T-test and a value of less than 0.05 was considered statistically 
significant.
Results
The study was carried out at St Thomas Hospital between Jan 2007 and Jan 2009 and all 39 
patients completed 6 months of follow up.                                                       
Patient  characteristics                                           
39 patients, 27 male were studied and underwent an ablation procedure.  The mean patient age 
was 60.8 years (range 39 - 77 yrs), mean duration of AF 7.5±0.9 years and average LA size 
4.2±1.0 cm. At enrolment 25 patients had paroxysmal AF and 14 had persistent AF. 12 patients 
had undergone a previous pulmonary vein isolation procedure. One patient enrolled was found 
subsequently  at  electrophysiological  study  to  have  left  atrial  flutter  and  was  not  included 
further  in  the study.  Patient  characteristics  including number  of  previous  AADs failed  are 
shown in Table 1.
Table 1: Patient characteristics
* Hypertension, diabetes mellitus, mitral valvular heart disease, heart failure
Acute ablation success                                                                     
All 4 major pulmonary veins were isolated in all but one patient in whom it was not possible to 
isolate  the  right  lower  pulmonary  vein.                                           
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Patient  symptoms                                               
In the  total  group 18 of  the 39 patients  were asymptomatic  at  6  months,  10 had reduced 
symptoms  and  11  remained  symptomatic.  The  corresponding  figures  for  paroxysmal  and 
persistent AF are shown in Table 2. This demonstrates that more than 70% of patients in both 
paroxysmal and persistent AF reported an improvement in their symptoms. Interestingly, 50% 
of the persistent AF group were asymptomatic compared to 44% in the paroxysmal AF group. 
Table 2: Patient symptoms and mean AF burden at 0, 3 and 6 months
N= number of patients. AF burden = hours in AF during 72 hour Holter. Sinus rhythm = sinus rhythm throughout 
72 hour Holter. Students paired t-test was used to determine statistical significance.
AF burden, anti-arrhythmics  and sinus rhythm at follow up                           
The number of patients in sinus rhythm at 3 and 6 months in the paroxysmal and persistent 
groups and the AF burden from the Holter data are also shown in Table 2. At 6 months, 18 of 
the 39 patients were asymptomatic, 10 had improved symptoms and 22 were in sinus rhythm. 
In the paroxysmal group, 11 were asymptomatic, 7 had improved symptoms and 16 (64%) 
were  in  sinus  rhythm.  In  the  persistent  group,  7  were  asymptomatic,  3  had  improved 
symptoms and 6 (43%) were in sinus rhythm. At 6 months, all 16 PAF patients who were in 
sinus  rhythm  came  off  anti-arrhythmics  whilst  those  with  recurrences  (9  patients)  were 
maintained on their baseline medication: 7 patients on Beta-blockers, 5 on flecainide and 2 on 
calcium  channel  blockers  (4  with  one  anti-arrhythmic  and  5  on  two  anti-arrhythmics).  3 
patients came off amiodarone.  In the persistent AF group, 9 patients came off amiodarone 
whilst the others were maintained on their baseline anti-arrhythmics:  12 on beta-blockers, 3 on 
amiodarone, 2 on calcium channel blockers and 2 on digoxin (4 on a single anti-arrhythmic, 3 
with two anti-arrhythmics and 3 on three  anti-arrhythmics). There was a significant reduction 
in AF burden in the persistent AF group at 6 months (P<0.01) with 43% of this group holding 
sinus rhythm throughout the 3 day holter. Two patients had gap related atrial flutter on their 3 
month  Holter  monitor.  All  patients  with  recurrences  were  listed  for  a  re-do  procedure.  
Procedural  times  and  catheter  performance  data                               
The mean procedural time was 217 ± 12 minutes with a mean fluoroscopy time of 37 ± 2 
minutes.  The  average  number  of  RF  applications  per  patient  was  52  (range  12  to  90).  
Dichotomising  procedural  times  into  paroxysmal  and persistent  AF groups,  the  values  are 
206±15 minutes  and 248±10  minutes  respectively.                                    
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The mean catheter temperature, impedance and watts achieved in the first 29 study patients are 
shown in Figure 3. The mean temperature achieved was 49.9±0.4 °C, mean power delivered 
was 11.9±0.3 W and mean impedance encountered 227.7±8.5 ohms. A tabulated recording of 
this similar means achieved at each of the 16 catheter poles for the same study patients are 
presented in Table 3.
Figure 3: Ablation catheter  temperature,  power and impedance  - mean values in the first  twenty nine study 
patients. Means ± SEM - Power=11.9±0.3W, Temperature=49.9±0.4 °C, Impedance=227.7±8.5 ohms               
Complications  and  safety                                           
No direct complication related to the catheter was observed. Two patients developed acute back 
burns, attributed to incorrectly sized back pads. After this problem was identified correct back 
pads were used in all  subsequent  cases  and no further  burns were observed.  2 patients had 
cardiac  tamponade  requiring  pericardiocentesis.  2  patients  developed  gap  related  left  atrial 
flutter  requiring  catheter  ablation.  A  third  patient  has  developed  left  atrial  flutter  after 
completion  of  the  study  period.  No  patient  suffered  a  transient  ischemic  attack  or  stroke. 
Catheter charring was not  observed during any of  the procedures.                          
Discussion
AF  burden/Clinical  outcome/Symptoms                                     
In  this  study  the  AF burden  was  found to  be  significantly  reduced  for  the  total  study  and 
persistent AF groups following linear ablation. Although statistically non significant there was 
also a reduction in AF burden at 6 months in the paroxysmal group. Out of 39 patients, only 
three patients had a higher AF burden post than pre procedure.  Of particular note is that almost 
half  the  persistent  AF patients,  all  of  whom were  in  AF pre-procedure,  were  holding sinus 
rhythm at 6 months after a single procedure. Interestingly in our study cohort, persistent patients 
who failed the ablation procedure universally returned to AF and none converted from persistent 
to paroxysmal AF.
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Table 3: Ablation catheter temperature, power and impedance per each of the 16 poles in the 
first 29 study patients
Data = mean ± SEM
The proportion of  patients  in  the paroxysmal  group demonstrating improved symptoms was 
greater than in the persistent group. However the reduction in AF burden on Holter was not as 
high  as  expected  given  this  improvement  in  symptoms.  Explanations  for  symptomatic 
improvement despite continuing AF could include ganglionic plexus modification or placebo 
effect.  
Catheter  performance                                        
The presented data suggests that the Cardima Revelation linear ablation catheter system can be 
used to achieve acute pulmonary vein isolation. Conduction block into the pulmonary veins is 
strongly suggestive of effective lesion application and this end point which was convincingly 
demonstrated in all but one patient. The energy delivered at each pole of the catheter during the  
60 to 90 second applications appears to be sufficient to achieve effective tissue destruction at the 
respective application site. Indeed split potentials and diminished electrograms demonstrable in 
some but not all cases suggesting an adequate lesion depth has been achieved at each pole. The 
Intellitemp system was documented to deliver sufficient energy at up to 8 catheter poles at a 
time. The Intellitemp automatically notes if a pole goes out of range for temperature, power or 
impedance and appropriately responds for each ablation point, ie if impedance becomes high it 
will switch off power to that pole. This is indicated on the output of the device allowing for 
further ablation to be performed  again if necessary. The power delivered at the poles of the 
ablation catheter were generally much lower than single pole ablation. Two reasons behind this 
include  firstly  temperature  was  limited  to  50  degrees  to  avoid  excessive  overheating  and 
potential charring.  Secondly, the generator was limited to 100W such that on multiple poles 
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limited power was delivered although in general target temperatures were not always achieved. 
This suggests that a generator capable of delivering more RF energy than the 100W delivered 
through the Medtronic Atakar may be more effective. For this study, given this being the first 
clinical setting in utilising the catheter and for safety reasons, a more conservative lower power 
delivery was employed.  Future evaluation of cautious up-titration of power delivery would be 
needed. The target temperature and power  settings in this study was the same for each pole and 
similar  settings  were  used  for  PV  isolation  and  all  lines  (including  roof  lines).  Catheter 
manipulation can be difficult in some cases due to its longer length and may explain why the 
procedural times observed were not shorter than conventional burn and drag techniques in our 
laboratory. Manipulation of this catheter might be improved with operator experience following 
the learning curve and with the use of a steerable sheath (Cardima Naviport ®).                 
Acute  results                                         
In this study the pulmonary veins were isolated in all but one case. The right lower pulmonary 
vein was the most difficult to isolate. This was on some occasion undertaken using the tip of the 
catheter (poles 1 and 2) to deliver directed local lesions. In some cases the catheter structure 
became  distorted,  but  removal  of  catheter  with  manual  reshaping  was  feasible.  Linear 
application in the right atrium was easier to perform than in the left atrium and placement of the 
right sided lesions took less than 20 minutes. In terms of procedural time, this linear ablation 
catheter technique was comparable to previous data using standard ablation catheters/ablation 
techniques. The procedural time in the persistent patients with the addition of a RA MAZE was 
not longer than in those with PAF. This may be because in many of the persistent patients there 
was not much signal in the pulmonary veins at the start, with most of the procedure then directed 
towards bi-atrial compartmentalisation. The addition of a RA MAZE only added on average 20 
mins  to  the  total  procedure  time.                                               
Safety  
The catheter proved to be safe in this study as evident by no embolic complications. The lack of 
charring of the catheter may partly explain this observation. This study demonstrates that the 
catheter can be used safely in the left atrium. Using the correct back pads is necessary with this 
catheter  given  the  significant  energy  delivered  through  them.  Smaller  back  pads  were 
inadvertently  placed  for  procedures  on  2  patients  resulting  in  superficial  back  burns. 
Subsequently in every case two back plates were used and no further burns occurred. The rates 
of tamponade and of LA flutter were similar to those described with conventional techniques (2-
4%) [11,12]. Whilst no odynophagia and formal oesophageal injury was reported, an evaluation 
for potential injury was not performed. The current standard during RF ablation for AF utilizes 
irrigated tip catheters. The absence of irrigation in this catheter did not result in any subsequent  
clinical diagnosis of thrombo-embolic events  although no formal evaluation of cerebral blood 
flow  was  performed.                                                     
Study  Limitations                                   
The  main  limitation  of  this  study  was  that  not  all  ablation  lines  were  checked  and  block 
confirmed by pacing techniques. In determining post procedure AF burden, study patients were 
only monitored  for  72 hours.  24  to  72  hours  of  monitoring  of  Holter  monitoring  has  been 
recommended by the HRS/ACC/ESC societies for monitoring AF burden in the follow up of 
subjects in AF ablation trials, as documented in their 2007 consensus statement on AF catheter  
ablation [13]. However it is quite possible that AF occurs outside this 'snapshot' time period and 
an implanted loop recorder would be useful for accurate follow up of AF burden for a more 
clinically  relevant  longer  and continuous time period.  Also longer  term follow-up would be 
useful to evaluate post-ablation atrial tachycardia occurrence.                                 
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Conclusion
In our initial experience, use of this linear ablating system within the left and right atrium to 
mimic Cox's MAZE procedure is feasible and safe. Further developments of this catheter and 
technique may reduce procedure times and increase therapeutic efficacy. A larger randomized 
study should be performed to evaluate the efficacy of this linear ablating system in assessing 
clinical  outcomes.                                             
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